e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Respiratory infections: a combination of problems needing early treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patterns of disease in patients with middle lobe predominant non-cystic fibrosis bronchiectasis
M. Ahmed, M. McDonnell, C. Donagh, D. Wall, M. O'Mahony, D. Breen, J. J. Gilmartin, J. Bruzzi, A. O'Regan, R. Rutherford (Galway, Ireland)
Source:
Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Session:
Respiratory infections: a combination of problems needing early treatment
Session type:
Thematic Poster Session
Number:
2715
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ahmed, M. McDonnell, C. Donagh, D. Wall, M. O'Mahony, D. Breen, J. J. Gilmartin, J. Bruzzi, A. O'Regan, R. Rutherford (Galway, Ireland). Patterns of disease in patients with middle lobe predominant non-cystic fibrosis bronchiectasis. Eur Respir J 2013; 42: Suppl. 57, 2715
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018
The spectrum of Nocardia lung disease in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Identifying undiagnosed cystic fibrosis in adults with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 29-44
Year: 2018
Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage
Source: Eur Respir J 2003; 22: Suppl. 45, 504s
Year: 2003
Diagnosis and management of non-cystic fibrosis bronchiectasis in children
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018
Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
The pulmonary microbiome in non-cystic fibrosis bronchiectasis.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept